News | October 05, 2010

Edwards Opens New Transcatheter Valve Manufacturing Facility

October 5, 2010 – Edwards Lifesciences has opened a new 300,000-square-foot facility in Draper, Utah, allowing the company to significantly expand its manufacturing and development capabilities, especially in the transcatheter valve space.

By the end of the year, Edwards expects to transfer all existing operations and approximately 250 employees from its Midvale facility to Draper. Edwards has already begun manufacturing cardiac surgery systems products and accessories at the new location. Additionally, the company plans to hire up to 1,000 new employees.

The company already has European clearance for its Sapien transcatheter aortic valve and is seeking approval from the U.S. Food and Drug Administration. Positive first-year results from its U.S. PARTNER Trial were released during the Transcatheneter Cardiovascular Therapeutics (TCT) 2010 symposium in September. Experts at TCT said transcatheter valves will likely replace current open-heart surgical valve repair in the next decade.

For more information: www.edwards.com

Related Content

First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
Overlay Init